The permeation characteristics of a model opioid peptide, HTyr-D-Ala-Gly-Phe-D-Leu-OH (DADLE), and its cyclic prodrugs [acyloxyalkoxy-based cyclic prodrug of DADLE (AOA-DADLE), coumarinic acid-based cyclic prodrug of DADLE (CA-DALE), and oxymethyl-modified coumarinic acid-based cyclic prodrug of DADLE (OMCA-DADLE)] across the blood-brain barrier (BBB) were determined using an in situ perfused rat brain model. The rat brains were perfused with Krebs-bicarbonate buffer containing test compounds in the absence or presence of a specific P-glycoprotein inhibitor (GF-120918). Brain samples were collected after perfusion and processed by a capillary depletion method. After liquid phase extraction with acetonitrile, samples were analyzed using high-performance liquid chromatography with tandem mass spectrometric detection. Linear uptake kinetics of DADLE and its cyclic prodrugs was observed within the range of 60 to 240 s of perfusion. The apparent permeability coefficient (P app ) of DADLE across the BBB was very low (Ͻ10 Ϫ7 cm/s), probably due to its unfavorable physicochemical properties (e.g., charge, hydrophilicity, and high hydrogen-bonding potential). All three cyclic prodrugs, however, also exhibited low membrane permeation (P app Ͻ10 Ϫ7 cm/s) in spite of their more favorable physicochemical properties (e.g., no charge, high hydrophobicity, and low hydrogen-bonding potential). Inclusion of GF-120918 (10 M) in the perfusates fully inhibited the P-gp activity in the BBB and dramatically increased the P app values of AOA-DADLE, CA-DADLE, and OMCA-DADLE by approximately 50-, 460-, and 170-fold, respectively. In contrast, GF-120918 had no effect on the P app value of DADLE. In addition, the observed bioconversions of the prodrugs to DADLE in the rat brains after 240-s perfusion were very low (5.1% from AOA-DADLE, 0.6% from CA-DADLE, and 0.2% from OMCA-DADLE), which was consistent with the in vitro bioconversion rates determined previously in rat brain homogenates.In an attempt to improve the blood-brain barrier (BBB) permeation of H-Tyr-D-Ala-Gly-Phe-D-Leu-OH (DADLE), an opioid peptide (Hill and Pepper, 1978;Iyengar et al., 1987;Prokai-Tatrai et al., 1996), our laboratory has synthesized cyclic prodrugs of this peptide using an acyloxyalkoxy (AOA) linker (Bak et al., 1999b), a coumarinic acid (CA) linker (Wang et al., 1999), and an oxymethyl-modified coumarinic acid (OMCA) linker (Ouyang et al., 2002a) (Fig. 1). Unlike DADLE, which is hydrophilic and charged, AOA-DADLE (Bak et al., 1999b), CA-DADLE (Wang et al., 1999), and OMCA-DADLE (Ouyang et al., 2002a) are lipophilic and uncharged. The physicochemical properties of these cyclic prodrugs of DADLE are indicative of solutes that have good cell membrane permeation characteristics (Pauletti et al., 1997).However, when the cell membrane permeation of these cyclic prodrugs of DADLE was evaluated using various in vitro cell culture models (e.g., Caco-2 cells and Madin-Darby canine kidney cells) (Bak et al., 1999a;Ouyang et al., 2002b; Tang and Borchardt, 2002a,b...